OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
Philip Arandjelovic, Youry Kim, James P. Cooney, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101178-101178
Open Access | Times Cited: 22

Showing 22 citing articles:

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure
Marie Armani-Tourret, Benjamin Bone, Toong Seng Tan, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 328-344
Closed Access | Times Cited: 25

A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models
Chiara Pavan, Kathryn C. Davidson, Natalie L. Payne, et al.
Cell stem cell (2025)
Open Access | Times Cited: 2

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
T Chou, Nishad S. Maggirwar, Matthew D. Marsden
Viruses (2024) Vol. 16, Iss. 7, pp. 1163-1163
Open Access | Times Cited: 10

Mcl-1 Protein and Viral Infections: A Narrative Review
Zbigniew Wyżewski, Justyna Stępkowska, Aleksandra Maria Kobylińska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1138-1138
Open Access | Times Cited: 5

Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
Yan Wang, Beibei Huang, Tingting Liang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101580-101580
Open Access | Times Cited: 5

Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
Susan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1900-1912
Open Access | Times Cited: 5

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV
Ellen Bowden-Reid, Ernest Moles, Anthony D. Kelleher, et al.
Drug Delivery and Translational Research (2025)
Open Access

Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
Ismail Hdoufane, Mehdi Oubahmane, Youssef Habibi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Ultrasound-Driven Coassembly of Anticancer Drugs into Carrier-Free Particles
M. Mohankumar, Soraia Fernandes, Francesca Cavalieri, et al.
ACS Nano (2025)
Closed Access

HIV Tat as a latency reversing agent: turning the tables on viral persistence
B Fisher, Paula M. Cevaal, Michael Roche, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes
Andrea Gramatica, Itzayana G. Miller, Adam R. Ward, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115652-115652
Open Access

Metformin Facilitates Viral Reservoir Reactivation and their Recognition by Anti-HIV-1 Envelope Antibodies
Augustine Fert, Jonathan Richard, Laurence Raymond Marchand, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110670-110670
Open Access | Times Cited: 3

Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules
Gayatri Nikhila Kadiyala, Sushama Telwatte, Adam Wedrychowski, et al.
AIDS (2024) Vol. 38, Iss. 9, pp. 1281-1291
Open Access | Times Cited: 2

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection
Weiwei Sun, Ce Gao, Gregory T. Gladkov, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 2

More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure
Jairo A. Fonseca, Alexis C. King, Ann Chahroudi
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 1, pp. 11-29
Open Access | Times Cited: 1

Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4+ T-Cells by Decreasing Viral Release
Augustine Fert, Jonathan Richard, Laurence Raymond Marchand, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

The EZH2 inhibitor tazemetostat mitigates HIV immune evasion, reduces reservoir formation, and promotes durable CD8+ T-cell revitalization
Andrea Gramatica, Itzayana G. Miller, Adam R. Ward, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIV
Julie Frouard, Sushama Telwatte, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Type I interferons sensitise HIV-1-reactivating T-cells for NK cell-mediated elimination despite HDACi-imposed dysregulation of innate immunity
Julia Prigann, Dylan Postmus, Anna Julia Pietrobon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2

AML With HIV Infection in The Era of Precision Oncology – Do We See The Light At The End of The Tunnel?
Sharada Mailankody, Ananth Pai, Ram Bhat, et al.
Indian Journal of Hematology and Blood Transfusion (2023) Vol. 40, Iss. 2, pp. 356-358
Closed Access

Highlights of the HIV cure session, 19th European AIDS Clinical Society (EACS) Conference, 18-21 October 2023, Warsaw, Poland
Christina Psomas, Sabine Kinloch-de Loës
Journal of Virus Eradication (2023) Vol. 9, Iss. 4, pp. 100359-100359
Open Access

Page 1

Scroll to top